PTSD Clinical Trial
Official title:
Concentrated Exposure Therapy for Post-traumatic Stress Disorder - a Cohort Study
Post-traumatic stress disorder (PTSD) is a prevalent and disabling condition. Trauma-focused psychotherapy, including cognitive behavioural therapy (CBT), are among the recommended first-line treatment alternatives. However, a substantial proportion of patients decline, drop-out or do not respond to current psychotherapies. Previous research suggests that intensive or concentrated formats of trauma-focused psychotherapy can lead to faster recover and lower attrition, but there are currently few studies of these approaches. The current study will investigate the acceptability. treatment satisfaction and preliminary changes in symptoms after four consecutive days of concentrated CBT for PTSD.
Status | Recruiting |
Enrollment | 42 |
Est. completion date | January 10, 2025 |
Est. primary completion date | January 10, 2025 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - fulfills DSM-5 criteria for PTSD - One or more single traumas in adolescence or adulthood - Speaks and writes Norwegian Exclusion Criteria: - New or unstable psychopharmacological treatment within last four weeks - fulfills ICD-11 criteria for complex PTSD - Ongoing substance abuse - Ongoing danger of suicide - Ongoing borderline personality disorder - Ongoing psychosis - Intellectual disability |
Country | Name | City | State |
---|---|---|---|
Norway | Haukeland University Hospital | Bergen | Vestland |
Lead Sponsor | Collaborator |
---|---|
Haukeland University Hospital | University of Bergen |
Norway,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Clinician-Administered PTSD Scale for DSM-5 (CAPS-5) | Clinician-administered interview to diagnose and the severity of PTSD | Change in scores from before treatment to one week after treatment | |
Primary | Clinician-Administered PTSD Scale for DSM-5 (CAPS-5) | Clinician-administered interview to diagnose and the severity of PTSD | Change in scores from one week after treatment to three months after treatment | |
Primary | Clinician-Administered PTSD Scale for DSM-5 (CAPS-5) | Clinician-administered interview to diagnose and the severity of PTSD | Change in scores from three months after treatment to twelve months after treatment | |
Secondary | Client Satisfaction Questionnaire 8 (CSQ-8) | Patient-rated questionnaire of treatment satisfaction | One week after treatment | |
Secondary | Client Satisfaction Questionnaire 8 (CSQ-8) | Patient-rated questionnaire of treatment satisfaction | Three months after treatment | |
Secondary | Client Satisfaction Questionnaire 8 (CSQ-8) | Patient-rated questionnaire of treatment satisfaction | Twelve months after treatment |
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT03962504 -
Written Exposure Therapy Versus Prolonged Exposure: a Non-inferiority Trial
|
N/A | |
Completed |
NCT01995123 -
Behavioral Activation for Smoking Cessation in PTSD
|
N/A | |
Not yet recruiting |
NCT06278922 -
Evaluating Signs of Safety: A Deaf-Accessible Therapy Toolkit for AUD and Trauma
|
N/A | |
Completed |
NCT04597450 -
Lu AG06466 in Participants With Post Traumatic Stress Disorder (PTSD)
|
Phase 1 | |
Completed |
NCT03593772 -
Mission Reconnect- Delivering a Mobile and Web Based Self Directed Complementary And Integrative Health Program to Veterans and Their Partners to Manage Pain and PTSD
|
N/A | |
Completed |
NCT03429166 -
Connecting Women to Care: Home-based Psychotherapy for Women With MST Living in Rural Areas
|
N/A | |
Recruiting |
NCT04317820 -
Deep Brain Reorienting in Post-traumatic Stress Disorder
|
N/A | |
Active, not recruiting |
NCT04588883 -
Strengthening Families Living With HIV in Kenya
|
N/A | |
Completed |
NCT03504722 -
Evaluating the Feasibility of RESCUE: An Adjunctive HAI-Based Intervention for Veterans With PTSD
|
N/A | |
Completed |
NCT04305353 -
Intensive Care Unit (ICU) Diary Project
|
N/A | |
Completed |
NCT03113890 -
McLean and Genomind Prospective Study
|
N/A | |
Withdrawn |
NCT05173831 -
Study of Feasibility and Safety of MDMA-Assisted Group Therapy for the Treatment of PTSD in Veterans
|
Phase 2 | |
Withdrawn |
NCT03924297 -
Chilipad for Sleep and Symptoms of PTSD
|
N/A | |
Not yet recruiting |
NCT04056767 -
Changes in Digital Phenotype During PE Therapy
|
||
Completed |
NCT03158558 -
Intensive Weekend Retreat Multi-Couple Group Therapy for PTSD
|
N/A | |
Completed |
NCT03343028 -
Biomarker Establishment for Superior Treatment of PTSD
|
||
Withdrawn |
NCT03216356 -
Effect of D-cycloserine on a Short Imagery Rescripting Intervention for Subclinical PTSD
|
Phase 2/Phase 3 | |
Completed |
NCT02370173 -
A Non-Pharmacological Method for Enhancing Sleep in PTSD
|
N/A | |
Completed |
NCT01955538 -
The Effect of BAT Versus Mixed Physical Activity as add-on Treatment for Traumatised Refugees.
|
Phase 3 | |
Completed |
NCT01911585 -
Efficacy of 60-minute Versus 90-minute Sessions in Treating PTSD Using Prolonged Exposure
|
N/A |